Natus Medical (BABY +8.5%) racks up a healthy gain on an upbeat FY13 forecast, and in spite of posting a mixed Q4 that beat on its EPS but missed on revenue. For Q1, the company sees EPS of $0.09 - $0.10 on revenues of $83M - $85M. Analysts are looking for $0.09 EPS on revenues of $83.94M. FY13 EPS is expected to be around $0.81 - $0.84 on revenues of $362M - $367M. The Street view is EPS of $0.82 on revenues of $359.02M.